Sort   by:  
 Page size 
UnknownAnti-Integrin αvβ6 Autoantibodies Are a Novel Biomarker That Antedate Ulcerative Colitis.
Not available
S-EPMC10284061 | biostudies-literature
UnknownAntigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial.
Not available
S-EPMC3580128 | biostudies-literature
UnknownA new approach for diagnosing type 1 diabetes in autoantibody-positive individuals based on prediction and natural history.
Not available
S-EPMC4302258 | biostudies-literature
UnknownHuman embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach.
Not available
S-EPMC3535399 | biostudies-literature
UnknownThe evolution and changing ecology of the African hominid oral microbiome.
Not available
S-EPMC8157933 | biostudies-literature
UnknownCo-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial.
Not available
S-EPMC3462593 | biostudies-literature
UnknownLow-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA1c in New-Onset Type 1 Diabetes.
Not available
S-EPMC6105329 | biostudies-literature
UnknownRisankizumab for Ulcerative Colitis: Two Randomized Clinical Trials.
Not available
S-EPMC11264075 | biostudies-literature
UnknownRationale and design of the glycemia reduction approaches in diabetes: a comparative effectiveness study (GRADE).
Not available
S-EPMC3714493 | biostudies-literature
UnknownElevated serum levels of interleukin-18 discriminate Still's disease from other autoinflammatory conditions: results from the European ImmunAID cohort.
Not available
S-EPMC12060884 | biostudies-literature
Sort   by:  
 Page size